日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis

按体重指数校正的甲氨蝶呤剂量评估托法替尼和阿达木单抗治疗类风湿性关节炎的疗效和安全性：一项事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00823-0
Takeuchi, Tsutomu; Tanaka, Yoshiya; Yamanaka, Hisashi; Yamaoka, Kunihiro; Sugiyama, Naonobu; Iikuni, Noriko; Toyoizumi, Shigeyuki; Kwok, Kenneth; Tsai, Wen-Chan; Mysler, Eduardo; Moots, Robert J; Smolen, Josef S; Fleischmann, Roy
关节炎
发表日期：2026
文献求助 收藏

Involving children in global health policy and programming: practical guidance to get started

让儿童参与全球卫生政策和规划：入门实用指南

期刊:Health Promotion International
影响因子:2.4
doi:10.1093/heapro/daaf041
Mathews, Gabrielle; Jennings, Bethany; Sterlini, Sarah; Prost, Audrey; Mudaly, Almaaz; Kwok, Kenneth; Cohen, Jason; Rizzini, Irene; Foley, Maree; English, Sonora; Rajagopalan, Srivatsan; Abdulkareem, Toyyib O; Dalglish, Sarah L
发表日期：2025
文献求助 收藏

Low intensity cognitive behavioral therapy to improve psychological well-being among family carers of older adults in Hong Kong: a cluster randomized controlled trial study protocol

低强度认知行为疗法改善香港老年人家庭照护者心理健康：一项整群随机对照试验研究方案

期刊:Trials
影响因子:2
doi:10.1186/s13063-025-09347-y
Tsoi, Tom Chun Wai; Kwok, Kenneth Yu Hon; Chan, Wai Sze; Tang, Vera Mun Yu; Chandola, Tarani; Quan, Jianchao; Lou, Vivian Weiqun
神经科学
发表日期：2025
文献求助 收藏

Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

托法替尼与TNF抑制剂治疗类风湿性关节炎患者发生延长主要不良心血管事件终点的风险：一项3b/4期随机安全性研究的事后分析

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2023-003912
Buch, Maya H; Bhatt, Deepak L; Charles-Schoeman, Christina; Giles, Jon T; Mikuls, Ted; Koch, Gary G; Ytterberg, Steven; Nagy, Edward; Jo, Hyejin; Kwok, Kenneth; Connell, Carol A; Masri, Karim Richard; Yndestad, Arne
关节炎
发表日期：2024
文献求助 收藏

Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

更正：托法替尼在银屑病关节炎和类风湿性关节炎患者中9年上市后安全性监测

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00615-4
Burmester, Gerd R; Coates, Laura C; Cohen, Stanley B; Tanaka, Yoshiya; Vranic, Ivana; Nagy, Edward; Lazariciu, Irina; Chen, All-Shine; Kwok, Kenneth; Fallon, Lara; Kinch, Cassandra
关节炎
银屑病
发表日期：2024
文献求助 收藏

Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies

根据在初始研究中达到的早期、中期或晚期反应，评估依那西普治疗放射学轴性脊柱关节炎患者的长期疗效

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00656-3
Baraliakos, Xenofon; Szumski, Annette E; Kwok, Kenneth K; Vlahos, Bonnie; Borlenghi, Cecilia E
关节炎
发表日期：2024
文献求助 收藏

Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials

种族对托法替尼治疗类风湿性关节炎的疗效和安全性的影响：汇总临床试验的事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00677-y
Wright, Grace C; Mysler, Eduardo; Kwok, Kenneth; Cadatal, Mary Jane; Germino, Rebecca; Yndestad, Arne; Kinch, Cassandra D; Ogdie, Alexis
关节炎
发表日期：2024
文献求助 收藏

Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

在伴或不伴有动脉粥样硬化性心血管疾病史的类风湿性关节炎患者中，托法替尼与肿瘤坏死因子抑制剂相比发生主要不良心血管事件的风险：一项来自 ORAL Surveillance 的事后分析

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard-2022-222259
Charles-Schoeman, Christina; Buch, Maya H; Dougados, Maxime; Bhatt, Deepak L; Giles, Jon T; Ytterberg, Steven R; Koch, Gary G; Vranic, Ivana; Wu, Joseph; Wang, Cunshan; Kwok, Kenneth; Menon, Sujatha; Rivas, Jose L; Yndestad, Arne; Connell, Carol A; Szekanecz, Zoltan
肿瘤
肿瘤免疫
心血管疾病
心血管
关节炎
动脉粥样硬化
发表日期：2023
文献求助 收藏

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

心血管风险富集对托法替尼治疗类风湿性关节炎临床项目中主要不良心血管事件发生率的影响

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard-2022-223406
Dougados, Maxime; Charles-Schoeman, Christina; Szekanecz, Zoltán; Giles, Jon T; Ytterberg, Steven R; Bhatt, Deepak L; Koch, Gary G; Vranic, Ivana; Wu, Joseph; Wang, Cunshan; Kwok, Kenneth; Menon, Sujatha; Connell, Carol A; Yndestad, Arne; Rivas, Jose L; Buch, Maya H
关节炎
发表日期：2023
文献求助 收藏

Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme

根据基线心血管风险评估接受托法替尼治疗的溃疡性结肠炎患者的主要不良心血管事件：来自 OCTAVE 临床项目的数据

期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjad104
Schreiber, Stefan; Rubin, David T; Ng, Siew C; Peyrin-Biroulet, Laurent; Danese, Silvio; Modesto, Irene; Guo, Xiang; Su, Chinyu; Kwok, Kenneth K; Jo, Hyejin; Chen, Yan; Yndestad, Arne; Reinisch, Walter; Dubinsky, Marla C
结肠炎
肠炎
发表日期：2023
文献求助 收藏